AI Science Tracker
EN

Detecting cardiomyopathies in pregnancy and the postpartum period with an electrocardiogram-based deep learning model

Department of Cardiovascular Medicine, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA; Department of Quantitative Health Sciences, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA; Department of Cardiovascular Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA; Department of Transplant Medicine, Mayo Clinic, 4500 San Pablo Rd, Jacksonville, FL 32224, USA; Department of Maternal and Fetal Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA; Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA; Department of Cardiovascular Diseases, Olmsted Medical Center, 210 Ninth Street SE Rochester, MN 55904, USA; Department of Physiology and Biomedical Engineering, Mayo Clinic, 200 First St SW, Rochester, MN 55905, USA · 27 Aug 2021 · medicine

Discovery

Detecting cardiomyopathies in pregnancy and the postpartum period with an electrocardiogram-based deep learning model

Source check: Source checked. Not independent scientific confirmation.

Finding: Among 1,807 women, the model’s AUC was 0.92 for LVEF ≤35%, 0.89 for <45%, and 0.87 for <50%; the strict-threshold AUC exceeded natriuretic peptide and clinical-variable comparators. The primary study includes 1,807 Mayo Clinic-system women with ECG and echocardiography; the model was evaluated against LVEF-defined cardiomyopathy and compared with biomarkers and a multivariable clinical model. Retrospective diagnostic evidence, not prospective outcome benefit.

Technology: An ECG-based deep-learning model screened for cardiomyopathy in pregnant and postpartum women using 12-lead ECGs.

Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.

AI contribution
An ECG-based deep-learning model screened for cardiomyopathy in pregnant and postpartum women using 12-lead ECGs.
Test and result
Among 1,807 women, the model’s AUC was 0.92 for LVEF ≤35%, 0.89 for <45%, and 0.87 for <50%; the strict-threshold AUC exceeded natriuretic peptide and clinical-variable comparators.
Limitation / still unknown
The primary study includes 1,807 Mayo Clinic-system women with ECG and echocardiography; the model was evaluated against LVEF-defined cardiomyopathy and compared with biomarkers and a multivariable clinical model. Retrospective diagnostic evidence, not prospective outcome benefit.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC8715757/

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review date: 22 Nov 2026. Review scope: Primary source full text Methods and Results; version/date checked against bibliographic record..

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 2/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open in the full catalog for filters, charts and related discoveries. Browse medicine discoveries.